# Active Pharmaceutical Ingredients

Type: Product

Source: GetYourBrief — https://getyourbrief.com/entity/active-pharmaceutical-ingredients
Canonical HTML page: https://getyourbrief.com/entity/active-pharmaceutical-ingredients

## Recent coverage (3 stories, network-wide)

### EU's 4 China-reliant sectors face supply chain overhaul toward India
2026-09-12 21:20:49 · Sector: supply · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A new report urges the EU to copy the UK's playbook for decoupling critical supply chains from China by shifting electronics, solar components, pharmaceuticals, and rare earths sourcing toward India. Procurement and manufacturing leaders should note the call for a phased, sector-by-sector transition rather than an abrupt switch.
Full story: https://getsupplybrief.com/story/eu-china-supply-dependency-india-diversification

### India Must Move Beyond Generics to Secure Global Health Supply Chains in 2026
2026-09-07 00:25:17 · Sector: health · Sentiment: Positive · Impact: 6/10 · Sources: 2

Piyush Goyal's Bharat Health Global Expo 2026 speech frames Indian pharma as a reliability partner for global healthcare supply chains. For healthcare systems, rebuilding API/KSM capability and moving beyond generics could reduce drug shortage risks. Policy emphasis on indigenous production may shift where hospitals and payers source critical medicines.
Full story: https://gethealthbrief.com/story/india-pharma-resilient-health-supply-chains-2026

### 2026 Expo: India Must Lead in New Molecules and Biotech, Says Goyal
2026-09-07 00:25:08 · Sector: bio · Sentiment: Positive · Impact: 6/10 · Sources: 2

For biotech and pharma professionals, Piyush Goyal's speech signals a policy pivot from generics to innovation. The minister explicitly called for leadership in R&D, new molecular entities, and biotechnology, while acknowledging past API/KSM losses. This may reshape funding and regulatory priorities for Indian drug developers.
Full story: https://getbiobrief.com/story/india-pharma-rd-new-molecules-biotech-goyal-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.